Healthcare Insights by KYBORA

In this episode, Alan sits down with Nicolas Coudurier, CEO of Biocodex, for a conversation on leading a family-owned global giant, the strategic integration of AI, the evolution of microbiome science and its connection to the brain. Nicolas shares insights from his career journey, including what it takes to drive continuous change while successfully scaling across several subsidiaries.

In this episode, Alan sits down with David H. Crean,Chief Business Officer at MediciNova, for a conversation on leadership,strategy, and navigating complexity in the biopharma industry.David shares insights from his career journey and whatit takes to build value in late-stage biotech. They explore decision-making inhigh-risk environments, the role of strategic partnerships, and the challengesof advancing innovation in neuroscience today. 

In this episode of Healthcare Insights by KYBORA, our CEO & Founder, Alan Vanderborght, sits down with David Apelian, CEO at Theolytics, for a conversation about the industry. Together, they explore immunotherapy, AI, and the innerworkings of clinical trials.

In this episode, our CEO Alan Vanderborght sits down with William Compton, SVP, Digital Enabling Functions and Colleague Services at Pfizer. Together, they discuss the effects of AI on the industry and what the future may look like.

In this episode, KYBORA's CEO, Alan Vanderborght, sits down with Richard Davies, Deputy Chairman of the Board at Alvotech, for a conversation about Richard's extensive industry experience, the current state of Biopharma, funding hurdles and the future of the industry.

KYBORA's CEO, Alan Vanderborght, sits down with Raya Therapeutic Founder, Anjan Aralihalli, for an inspiring conversation about Anjan's background, ALS breakthroughs and how Raya Therapeutic came to be.

Join us for our third episode! KYBORA's CEO Alan Vanderborght invites Dr. Weiyong Sun, Chief Business Officer at Hansoh Bio, for an insightful conversation about current issues in the industry, including the impact of China's growing R&D capabilities on the US pharmaceutical business.

In this episode, KYBORA's CEO Alan Vanderborght, and guest Carlo De Notaristefani, President at CDN Advising, discuss supply chain management, tariff pressures and the evolution of the Biopharma industry.

In the first episode of our podcast, guest John Gregg and host Alan Vanderborght discuss John's time and extensive experience in the industry, as well as various scientific innovations and the future of the healthcare industry.